Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 208.83
+3.28 (1.60%)
Apr 29, 2026, 3:29 PM IST
Jagsonpal Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | 2021 - 2017 |
| Market Capitalization | 13,800 | 12,323 | 14,422 | 7,313 | 7,592 | 8,214 | Upgrade
|
| Market Cap Growth | -3.70% | -14.55% | 97.22% | -3.68% | -7.58% | 293.91% | Upgrade
|
| Enterprise Value | 12,821 | 10,819 | 13,741 | 6,290 | 7,175 | 7,748 | Upgrade
|
| Last Close Price | 205.55 | 184.03 | 215.01 | 108.21 | 112.14 | 121.33 | Upgrade
|
| PE Ratio | 32.58 | 28.60 | 26.05 | 32.55 | 28.41 | 43.57 | Upgrade
|
| PS Ratio | 4.61 | 4.12 | 5.37 | 3.50 | 3.21 | 3.78 | Upgrade
|
| PB Ratio | 5.00 | 4.46 | 6.01 | 3.90 | 4.78 | 6.19 | Upgrade
|
| P/TBV Ratio | 6.96 | 6.22 | 9.35 | 3.90 | 4.78 | 6.19 | Upgrade
|
| P/FCF Ratio | 29.57 | 26.41 | 26.24 | 20.94 | 16.39 | 140.06 | Upgrade
|
| P/OCF Ratio | 29.48 | 26.33 | 26.08 | 20.80 | 16.27 | 118.81 | Upgrade
|
| EV/Sales Ratio | 4.28 | 3.62 | 5.11 | 3.01 | 3.03 | 3.56 | Upgrade
|
| EV/EBITDA Ratio | 18.30 | 15.44 | 27.69 | 28.44 | 20.67 | 30.37 | Upgrade
|
| EV/EBIT Ratio | 21.15 | 17.85 | 32.00 | 29.11 | 21.18 | 32.30 | Upgrade
|
| EV/FCF Ratio | 27.47 | 23.19 | 25.01 | 18.01 | 15.49 | 132.10 | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.12 | 0.12 | 0.18 | 0.38 | 0.17 | - | Upgrade
|
| Debt / FCF Ratio | 0.18 | 0.18 | 0.17 | 0.26 | 0.13 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.35 | -0.50 | -0.74 | -0.68 | -0.35 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.40 | -1.40 | -2.41 | -6.29 | -3.13 | -1.84 | Upgrade
|
| Net Debt / FCF Ratio | -2.10 | -2.10 | -2.17 | -3.98 | -2.34 | -8.02 | Upgrade
|
| Asset Turnover | 1.01 | 1.01 | 1.09 | 1.01 | 1.32 | 1.33 | Upgrade
|
| Inventory Turnover | 7.00 | 7.00 | 6.42 | 4.52 | 3.68 | 3.02 | Upgrade
|
| Quick Ratio | 4.36 | 4.36 | 5.48 | 8.31 | 4.92 | 2.32 | Upgrade
|
| Current Ratio | 5.06 | 5.06 | 6.22 | 10.29 | 5.97 | 4.04 | Upgrade
|
| Return on Equity (ROE) | 16.70% | 16.70% | 25.91% | 12.97% | 18.32% | 14.81% | Upgrade
|
| Return on Assets (ROA) | 12.74% | 12.74% | 10.84% | 6.55% | 11.79% | 9.13% | Upgrade
|
| Return on Invested Capital (ROIC) | 32.36% | 30.41% | 40.30% | 32.94% | 36.65% | 22.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.00% | 21.00% | 17.00% | 10.90% | 20.20% | 17.50% | Upgrade
|
| Earnings Yield | 3.12% | 3.50% | 3.84% | 3.07% | 3.52% | 2.30% | Upgrade
|
| FCF Yield | 3.38% | 3.79% | 3.81% | 4.78% | 6.10% | 0.71% | Upgrade
|
| Dividend Yield | 1.22% | - | 1.16% | 1.85% | 1.78% | 1.32% | Upgrade
|
| Payout Ratio | 38.67% | 38.67% | 23.90% | 58.31% | - | 55.58% | Upgrade
|
| Buyback Yield / Dilution | -1.40% | -1.40% | -1.56% | -1.23% | - | - | Upgrade
|
| Total Shareholder Return | -0.18% | -1.40% | -0.39% | 0.62% | 1.78% | 1.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.